GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Ltd: Board Meeting Rescheduled to July 31, 2026

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 29 Jul 2026, 12:25 PM IST  ·  BSE ID: 602df966-81f2-4f25-b92e-e352a5894160
View Original BSE Filing (PDF)
💡
In Simple Terms
SMS Pharmaceuticals changed its board meeting date for financial results to July 31, 2026.
🤖 AI Summary
  • SMS Pharmaceuticals Board Meeting moved to July 31, 2026, from August 1, 2026.
  • Meeting agenda includes approval of Unaudited Financial Results for Q1 FY2026.
  • Trading window for designated persons closes July 1, 2026, reopens August 3, 2026.
  • Rescheduling due to unavoidable administrative exigencies.
  • Company is SMS Pharmaceuticals Ltd, BSE symbol SMSPHARMA.
🏢 How This Affects the Company
⚙️
Operational Impact
The Board Meeting date has been preponed, requiring adjustments to internal schedules for financial result preparation and dissemination.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. Shareholders should note the revised date for the financial results announcement.
👤
Who Is Affected
All shareholders are indirectly affected as they will receive the financial results information on the revised date.
🔍
Management Signal
Management signals a commitment to transparency by adhering to regulatory timelines for financial disclosures, despite administrative challenges.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY2026 Unaudited Financial Results release on July 31, 2026.
Reopening of trading window on August 3, 2026.
Confirmation of Q1 FY2026 financial performance post-announcement.
LOW RISK The filing concerns a routine rescheduling of a board meeting, posing no new material risks.
💡 Investor Takeaway
SMS Pharmaceuticals Ltd has preponed its Board Meeting to July 31, 2026, to approve Q1 FY2026 Unaudited Financial Results. The trading window closure is from July 1, 2026, to August 2, 2026.
❓ Frequently Asked Questions
When is the rescheduled Board Meeting for SMS Pharmaceuticals Ltd?
The Board Meeting of SMS Pharmaceuticals Ltd has been rescheduled to July 31, 2026, from August 1, 2026.
What will be discussed at the SMS Pharmaceuticals Board Meeting on July 31, 2026?
The Board Meeting will consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the first quarter ended June 30, 2026.
When does the trading window close and reopen for SMS Pharmaceuticals Ltd?
The trading window for SMS Pharmaceuticals Ltd is closed from July 1, 2026, and will reopen on August 3, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.